Clinical Study of the photodynamic therapy for the periferal lung cancer
Not Applicable
- Conditions
- ung Cancer
- Registration Number
- JPRN-UMIN000015484
- Lead Sponsor
- ippon Medical School Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with anti-coagulant dose, except for salicylic acid formulation in the past week women who are/may pregnant, or lactating Patients with serious complications such as heart disease, liver disease and kidney failure Patients who have the porphyria Patients who have the sunlight hypersensitivity Maximum diameter of solid part adenocarcinoma of more than 50% of the nodule diameter Patients who have been determined to be inappropriate as a subject upon the doctor's discretion
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method frequency of adverse event of grade 2 or more within 180 days of PDT
- Secondary Outcome Measures
Name Time Method